Successful £2.4m funding round takes Lab901 Limited to the next level
Lab901 will use the cash injection to expand international sales of its ScreenTape® laboratory analysis platform and further develop its product range. Since launching in 2007, ScreenTape is now sold in more than 20 countries - including S. Korea, S. Africa, Canada, Venezuela , Malaysia and Mexico as well as many European countries - through a network of 16 distribution partners.
Commenting on the latest round of funding, Joel Fearnley, CEO and co-founder of Lab901, said: "Lab901 has an enviable track record with the successful development and commercialisation of the innovative ScreenTape platform and our existing investors have provided the finance we need to support planned global sales growth."
Most read news
Other news from the department business & finance
Get the analytics and lab tech industry in your inbox
From now on, don't miss a thing: Our newsletter for analytics and lab technology brings you up to date every Tuesday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.